NCT04696484

Brief Summary

This study aims to assess the feasibility of a new, brief intervention, the 'coopeRATE Prompt', for informing conversations between patients and physicians in routine tele-health and in-person adult Cystic Fibrosis (CF) care. The coopeRATE Prompt is two questions designed to elicit patients' concerns and goals to facilitate collaborative goal setting within the health care visit. This is a prospective single arm study that will be conducted at four CF care centers in the United States.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
219

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 4, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 6, 2021

Completed
8 days until next milestone

Study Start

First participant enrolled

January 14, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 3, 2021

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 19, 2021

Completed
Last Updated

November 24, 2021

Status Verified

November 1, 2021

Enrollment Period

8 months

First QC Date

January 4, 2021

Last Update Submit

November 23, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Use of intervention responses with physician (patient-reported)

    Patient-reported discussion of intervention responses (concerns and goals) in the visit with physician, assessed using two items with multiple choice (single answer) format. The first item assesses how many of the patient concerns were discussed and the second item assesses how many of the patient goals were discussed. Item response options are 'None of them', 'Some of them', or 'All of them'.

    Within 24 hours after completion of the healthcare visit

Secondary Outcomes (22)

  • Intervention completion (patient-reported)

    1-4 days before the healthcare visit

  • Intervention acceptability (patient-reported)

    1-4 days before the healthcare visit

  • Utility of intervention (patient-reported)

    Within 24 hours after completion of the healthcare visit

  • Way(s) in which intervention was helpful (patient-reported)

    Within 24 hours after completion of the healthcare visit

  • Initiator of discussion (patient-reported)

    Within 24 hours after completion of the healthcare visit

  • +17 more secondary outcomes

Other Outcomes (6)

  • Concerns and goals (patient-reported)

    1-4 days before the healthcare visit and within 24 hours after completion of the healthcare visit

  • Additional intervention feedback (patient-reported)

    1-4 days before the healthcare visit and within 24 hours after completion of the healthcare visit

  • Type of routine healthcare visit (patient-reported)

    Within 1 month following completion of patient data collection

  • +3 more other outcomes

Study Arms (1)

Intervention

EXPERIMENTAL

coopeRATE Prompt

Behavioral: coopeRATE Prompt

Interventions

The coopeRATE Prompt intervention is a set of two questions delivered to patients before the clinical encounter that elicit their concerns and goals. The intervention is delivered to patients online, outside the clinic setting.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have a diagnosis of CF
  • are 18 years of age or older
  • can read and write English
  • have a scheduled in-person or tele-health routine CF care visit
  • have access to internet and email

You may not qualify if:

  • does not have a diagnosis of CF
  • is less than 18 years of age
  • cannot read and write English
  • does not have a scheduled in-person or tele-health routine CF care visit
  • does have access to internet and email

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

National Jewish Health

Denver, Colorado, 80206, United States

Location

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

Dartmouth-Hitchcock

Lebanon, New Hampshire, 03756, United States

Location

University of Virginia

Charlottesville, Virginia, 22908, United States

Location

Related Publications (4)

  • Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3.

    PMID: 28851459BACKGROUND
  • Dalcin AT, Jerome GJ, Fitzpatrick SL, Louis TA, Wang NY, Bennett WL, Durkin N, Clark JM, Daumit GL, Appel LJ, Coughlin JW. Perceived helpfulness of the individual components of a behavioural weight loss program: results from the Hopkins POWER Trial. Obes Sci Pract. 2015 Oct;1(1):23-32. doi: 10.1002/osp4.6. Epub 2015 Sep 9.

    PMID: 27668085BACKGROUND
  • Elwyn G, Barr PJ, Grande SW, Thompson R, Walsh T, Ozanne EM. Developing CollaboRATE: a fast and frugal patient-reported measure of shared decision making in clinical encounters. Patient Educ Couns. 2013 Oct;93(1):102-7. doi: 10.1016/j.pec.2013.05.009. Epub 2013 Jun 12.

    PMID: 23768763BACKGROUND
  • Barr PJ, Thompson R, Walsh T, Grande SW, Ozanne EM, Elwyn G. The psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process. J Med Internet Res. 2014 Jan 3;16(1):e2. doi: 10.2196/jmir.3085.

    PMID: 24389354BACKGROUND

MeSH Terms

Conditions

Cystic FibrosisChronic Disease

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Glyn Elwyn

    Dartmouth College

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 4, 2021

First Posted

January 6, 2021

Study Start

January 14, 2021

Primary Completion

September 3, 2021

Study Completion

September 19, 2021

Last Updated

November 24, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will share

A de-identified copy of participant-level data and essential analytic code will be made available to others for research purposes, via data sharing.

Shared Documents
ANALYTIC CODE
Time Frame
The data and supporting information will be available after December 2021 and for an indefinite period of time.
Access Criteria
Requests must include sufficient justification for the data which does not duplicate any current or planned data use. All requests will be subject to Investigator approval.

Locations